HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Fumiko Sekiguchi Selected Research

zinc chloride

2/2015Roles of Cav3.2 and TRPA1 channels targeted by hydrogen sulfide in pancreatic nociceptive processing in mice with or without acute pancreatitis.
7/2012Hydrogen sulfide-induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Fumiko Sekiguchi Research Topics

Disease

20Hyperalgesia
02/2015 - 03/2004
13Pain (Aches)
02/2015 - 03/2004
7Stroke (Strokes)
04/2004 - 04/2002
6Inflammation
02/2015 - 12/2003
5Pancreatitis
02/2015 - 05/2006
4Neoplasms (Cancer)
07/2010 - 05/2006
3Edema
02/2015 - 08/2006
3Cystitis
02/2015 - 10/2012
3Breast Neoplasms (Breast Cancer)
07/2010 - 03/2002
2Neuralgia (Stump Neuralgia)
01/2013 - 07/2010
2Adenocarcinoma
01/2010 - 12/2008
2Colorectal Neoplasms (Colorectal Cancer)
12/2008 - 05/2006
2Hypertension (High Blood Pressure)
07/2004 - 07/2003
1Peptic Ulcer (Peptic Ulcers)
02/2015
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
02/2015
1Disseminated Intravascular Coagulation
11/2013
1Intractable Pain
01/2013
1Referred Pain
01/2012
1Disease Progression
07/2010
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2009
1Colitis
10/2009
1Ischemia
11/2007
1Stomach Neoplasms (Stomach Cancer)
05/2007
1Bone Resorption
08/2006
1Arthritis (Polyarthritis)
08/2006

Drug/Important Bio-Agent (IBA)

9Hydrogen Sulfide (Sulfide, Hydrogen)IBA
02/2015 - 11/2007
6(1S,2S)- 2- (2- (N- ((3- benzimidazol- 2- yl)propyl)- N- methylamino)ethyl)- 6- fluoro- 1,2,3,4- tetrahydro- 1- isopropyl- 2- naphtyl cyclopropanecarboxylate dihydrochlorideIBA
02/2015 - 01/2012
6sodium bisulfide (NaHS)IBA
02/2014 - 11/2007
5Caerulein (Ceruletide)IBA
02/2015 - 05/2006
4EnzymesIBA
02/2015 - 05/2006
4Protein Isoforms (Isoforms)IBA
02/2015 - 07/2012
4T-Type Calcium Channels (T-Type Calcium Channel)IBA
01/2013 - 03/2009
4MibefradilIBA
10/2012 - 11/2007
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2015 - 10/2012
3Neutralizing AntibodiesIBA
04/2014 - 06/2004
3Cysteine (L-Cysteine)FDA Link
10/2012 - 11/2007
3Phenobarbital (Luminal)FDA Link
01/2012 - 03/2004
3trastuzumab (Herceptin)FDA Link
07/2010 - 03/2002
3capecitabine (Xeloda)FDA Link
05/2007 - 03/2002
3Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2003 - 12/2002
3Caffeine (No Doz)FDA LinkGeneric
04/2003 - 04/2002
2zinc chlorideFDA Link
02/2015 - 07/2012
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
02/2015 - 07/2012
2CystathionineIBA
02/2015 - 10/2012
2HMGB1 Protein (HMG1)IBA
04/2014 - 11/2013
2ThrombomodulinIBA
04/2014 - 11/2013
2Ethosuximide (Zarontin)FDA LinkGeneric
02/2013 - 11/2007
2propargylglycineIBA
07/2010 - 11/2007
23-cyanoalanineIBA
07/2010 - 11/2007
2Messenger RNA (mRNA)IBA
10/2009 - 05/2007
2Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA
10/2009 - 11/2007
2TrypsinIBA
05/2007 - 05/2006
2Proteinase-Activated ReceptorsIBA
06/2005 - 03/2004
27- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA
07/2004 - 12/2003
2NG-Nitroarginine Methyl Ester (L-NAME)IBA
07/2004 - 10/2002
1Staphylococcal Protein A (A, Protein)IBA
02/2015
1CarnosineIBA
02/2015
1polaprezinc (Z 103)IBA
02/2015
1ZincIBA
02/2015
1ThrombinFDA Link
04/2014
1Toll-Like Receptor 4IBA
04/2014
1advanced glycosylation end-product receptorIBA
04/2014
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
04/2014
1sodium sulfideIBA
02/2014
1Nuclear Proteins (Protein, Nuclear)IBA
11/2013
1Dacarbazine (DIC)FDA LinkGeneric
11/2013
1Prostaglandins E (PGE)IBA
02/2013
1Cyclic AMP Receptors (Cyclic AMP Receptor)IBA
02/2013
1N- (3- methoxyphenyl)- 4- chlorocinnamanilideIBA
01/2013
1Analgesics (Analgesic Drugs)IBA
01/2013
1Opioid Receptors (Opioid Receptor)IBA
01/2013
1Buprenorphine (Subutex)FDA LinkGeneric
01/2013
1Carbon MonoxideIBA
11/2010
1PAR-2 ReceptorIBA
11/2010
1capsazepineIBA
11/2010
1nafamostatIBA
11/2010
1Small Interfering RNA (siRNA)IBA
07/2010
1taxaneIBA
07/2010
1CurcuminIBA
01/2010
1Thiosulfate Sulfurtransferase (Rhodanese)IBA
10/2009
1Dextran SulfateIBA
10/2009
1OligodeoxyribonucleotidesIBA
03/2009
1Interleukin-8 (Interleukin 8)IBA
12/2008
1Dithionitrobenzoic Acid (Ellman's Reagent)IBA
11/2007
1harpin (messenger)IBA
11/2007
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
09/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2007
1FOY 305 (camostat)IBA
05/2007
1Mesylates (Mesylate)IBA
05/2007
1Cisplatin (Platino)FDA LinkGeneric
05/2007
1Peptide Hydrolases (Proteases)IBA
05/2007
1DiphosphonatesIBA
08/2006
1Adenosine Triphosphate (ATP)IBA
08/2006
1Alendronate (Alendronate Sodium)FDA LinkGeneric
08/2006
1Etidronic Acid (HEDP)FDA LinkGeneric
08/2006
1Dihydrotachysterol (AT 10)IBA
08/2006

Therapy/Procedure

4Heterologous Transplantation (Xenotransplantation)
07/2010 - 03/2002
3Oral Administration
02/2013 - 05/2006
1Drug Therapy (Chemotherapy)
05/2007
1Analgesia
08/2006